ArticleCureus2026

Fatal Triple-M Overlap Syndrome After Atezolizumab-Bevacizumab Therapy in Advanced Hepatocellular Carcinoma: A Case Report of Diagnostic Complexity and Therapeutic Escalation With Ruxolitinib.

Jonathan Moyambi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.